NKX019, Intravenous Allogeneic Chimeric Antigen Receptor Natural Killer Cells (CAR NK), in Adults With B-cell Cancers
Nkarta, Inc.
Nkarta, Inc.
Novartis
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Autolus Limited
Alliance for Clinical Trials in Oncology
Eastern Cooperative Oncology Group
Memorial Sloan Kettering Cancer Center
Novartis
Galapagos NV
Children's Oncology Group
M.D. Anderson Cancer Center
PeproMene Bio, Inc.
Memorial Sloan Kettering Cancer Center
Dana-Farber Cancer Institute
City of Hope Medical Center